Log In
Print
BCIQ
Print
Print this Print this
 

Asparec (AZP-02)

Also known as: Pegylated recombinant Erwinia chrysanthemi L-asparaginase

  Manage Alerts
Collapse Summary General Information
Company Alize Pharma
DescriptionPegylated recombinant L-asparaginase from Erwinia chrysanthemi
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic: Enzyme
Latest Stage of DevelopmentPhase I
Standard IndicationAcute lymphoblastic leukemia (ALL)
Indication DetailsTreat acute lymphoblastic leukemia (ALL)
Regulatory Designation

EU - Orphan Drug (Treat acute lymphoblastic leukemia (ALL))

Partner

Jazz Pharmaceuticals plc


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today